Speaker illustration

Associate Professor Vojislav Giga

University of Belgrade, Belgrade (Serbia)

Date of birth: 20.11.1974 Education: Graduated from School of Medicine, University of Belgrade 2000. average grade 9.66/10 Specialization in internal medicine 2006. Master thesis in Cardiology: 2005 Phd thesis in Cardiology: 2016 Employement: Cardiology Clinic, Clinical Center of Serbia, Department of Noninvasive diagnostics from 2005 Assistant professor of Internal Medicine, School of Medicine, University of Belgrade 2012-2019 Associate professor of Internal Medicine, School of Medicine, University of Belgrade 2019 Field of interest Exercise testing, Primary and secondary prevention of cardiovascular diseases, Sports cardiology Scientific activities: 44 papers published in CCI journals Other activities: Secretary General - Cardiology Society of Serbia from 2017-2019 Board Member – Cardiology Society of Serbia from 2020 President of Working Group on Cardiovascular Disease Prevention 2013-2015 National Coordinator for CVD Prevention from 2013 (ongoing)

Comparison of SCORE and SCORE 2 model for cardiovascular risk stratification in men and women from high risk European country

Event: ESC Preventive Cardiology 2023

Topic: Scores

Session: Moderated ePoster 2

Thumbnail

Comparison of SCORE and SCORE 2 risk prediction tools in contemporary very high risk european population

Event: ESC Congress 2022

Topic: Scores

Session: Cardiovascular risk assessment - Scores 1

Thumbnail

Correlation between prognostic markers of stress echocardiography and angiographic severity of coronary artery disease in patients after primary PCI

Event: EuroEcho-Imaging 2016

Topic: Exercise stress echo

Session: HIT Poster session 3

Thumbnail

Long term prognostic value of heart rate recovery in patients with pre-test probability for coronary artery disease of 15-65% and negative exercise testing

Event: ESC Congress 2016

Topic: Exercise testing and training

Session: Exercise testing and training I

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb